NCT01569737View on ClinicalTrials.gov

Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

CompletedOBSERVATIONAL
Enrollment

98

Participants

Timeline

Start Date

November 18, 2014

Primary Completion Date

June 29, 2018

Study Completion Date

June 29, 2018

Conditions
Emergency Contraception
Interventions
DRUG

ella

ella, single intake, tablet 30mg

Trial Locations (1)

10001

Planned Parenthood Federation of America, Inc, New York

Sponsors

Lead Sponsor

HRA Pharma
All Listed Sponsors
lead

HRA Pharma

INDUSTRY

NCT01569737 - Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella | Biotech Hunter | Biotech Hunter